Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children

Pediatrics

Volumn 128, Issue 5, 2011, Pages

  Gilca, Rodica ^a,b,c   Deceuninck, Geneviève ^b   De Serres, Gaston ^a,b,c   Boulianne, Nicole ^a,b   Sauvageau, Chantal ^a,b,c   Quach, Caroline ^d   Boucher, François D ^b,c   Skowronski, Danuta M ^e,f  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Children; Effectiveness; Hospitalization; Influenza vaccine; Pandemic influenza

Indexed keywords

ADJUVANT; AS03; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ARTICLE; CANADA; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; INFLUENZA VACCINATION; MULTIPLE CYCLE TREATMENT; ONSET AGE; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD;

EID: 80355131224     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-3492     Document Type: Article

References (23)

1. Health Canada. Summary Basis of Decision (SBD) for AREPANRIX H1N1. Available at: www.hc-sc.gc.ca/dhp-mps/alt-formats/pdf/prodpharma/sbd-smd/phase1- decision/drug-med/sbd-smd-2010-arepanrix-h1n1-132070-eng.pdf. Accessed April 20, 2011
2. Health Canada. Product information leaflet Arepanrix H1N1 AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine - Version 4 approved 20 April 2010. Available at: www.hcsc.gc.ca/dhp-mps/prodpharma/legislation/interimorders-arretesurgence/ prodinfo-vaccin-eng.php. Accessed April 20, 2011
3. GlaxoSmithKline Inc. A study to evaluate the safety and immunogenicity of A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340273A in children 6 months to less than 9 years of age. Available at: http://download.gsk-clinicalstudyregister.com/files/3d226ebd-7b95-4336-bb27- 12dc16b231b9. Accessed April 20, 2011
4. GlaxoSmithKline Inc. Safety and immunogenicity study of GSK Biologicals' pandemic influenza candidate vaccine (GSK2340272A) in children aged 6 to 35 months. Available at: http://gsk.sylogent.com/files/27868.pdf. Accessed April 20, 2011
5. Sauvageau C, Gilca V. Avis complémentaire concernant la vaccination contre le virus pandémique influenza A (H1N1) 2009 pour les enfants de 6 mois à 9 ans. Québec, Canada: Institut national de santé publique du Québec; 2009. Available at: http://www.inspq.qc. ca/pdf/publications/1025-AvisVaccH1N1Enfants6-9Ans.pdf. Accessed April 20, 2011
6. NACI. Statement on seasonal trivalent inactivated influenza vaccine (TIV) for 2009-2010. CCDR RMTC. 2009;35(ACS-6):1-41
7. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Wolters Kluwer Health; 2008
8. Carmona A, Omenaca F, Tejedor JC, et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. Vaccine. 2010;28(36):5837-5844
9. Waddington CS, Walker WT, Oeser C, et al. Safety and immunogenicity of AS03B adjuvanted split virion versus nonadjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. BMJ. 2010;340:c2649
10. Nicholson KG, Abrams KR, Batham S, et al. Immunogenicity and safety of a 2-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, agestratified, head-to-head trial. Lancet Infect Dis. 2011;11(2):91-101
11. Van Buynder PG, Dhaliwal JK, Van Buynder JL, et al. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respi Viruses. 2010;4(4):171-178
12. Hardelid P, Fleming DM, McMenamin J, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 2011;16(2):pii= 19763. Available at: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763. Accessed April 20, 2011
13. Andrews N, Waight P, Yung CF, Miller E. Agespecific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis. 2011;203(1):32-39
14. Ortqvist A, Berggren I, Insulander M, Svenungsson B. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden. Clin Infect Dis. 2011;52(10):1203-1211
15. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med. 2010;7(4):e1000258
16. Janjua NZ, Skowronski DM, Hottes TS, et al. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis. 2010;51(9):1017-1027
17. Janjua NZ, Skowronski D, De Serres G, et al. Analysis of the Association Between 2008-09 Trivalent Influenza Vaccine (TIV) and Pandemic A/H1N1 Risk During the Fall 2009 [abstract]. Presented at the Options for the Control of Influenza VII (Abstract #4405), Hong Kong SAR, China; 2010
18. Cowling BJ, Ng S, Ma E, Cheng C, Wai W, Fang V. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus during the 2009 in Hong Kong. Clin Infect Dis. 2010;51(12):1370-1379
19. Skowronski DM, Janjua NZ, Hottes TS, De Serres G. Mechanism for seasonal vaccine effect on pandemic H1N1 risk remains uncertain. Clin Infect Dis. 2011;52(6):831-832
20. Nolan T, Richmond PC, Formica NT, et al. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine. 2008;26(50):6383-6391
21. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA. 2010;303(1):37-46
22. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2008;(2):CD004879
23. Kelly H, Jacoby P, Dixon GA, et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J. 2011;30(2):107-111